Search results
Global, US data show high antibiotic use, rise in resistant infections during COVID
Center for Infectious Disease Research and Policy· 21 hours agoTwo new studies highlight the impact that the COVID-19 pandemic has had on antibiotic use and...
FDA Approves ImmunityBio's Bladder Cancer Drug, Stock Rallies
Benzinga via Yahoo Finance· 4 days agoMonday, the FDA approved ImmunityBio Inc’s (NASDAQ:IBRX) Anktiva (N-803, or nogapendekin alfa...
Risks of Antipsychotic Use in Dementia Patients - Neuroscience News
Neuroscience News· 7 days agoSummary: A new study revealed significant risks associated with antipsychotic use in dementia...
Hospitalizations for RSV rose in 2021, 2022 for preschoolers
Center for Infectious Disease Research and Policy· 5 days agoIn 2021 and 2022, the virus appeared to peak early in several states and to cause more severe illness.
Apr 26 2024 This Week in Cardiology
Medscape· 1 day agoFor more insight and commentary on these stories, subscribe to the This Week in Cardiology podcast, download the Medscape app or subscribe on Apple...
Study Reveals State Cannabis Legalization Lowers Immigrant Deportation | High Times
High Times· 1 day agoAccording to new research, states that have legalized cannabis also experience a “moderate relative...
Elevate Your Health: Stair Climbing Unlocked as a Key to Longer Life
SciTechDaily· 1 day ago“If you have the choice of taking the stairs or the lift, go for the stairs as it will help your...
ImmunityBio Announces FDA Approval of ANKTIVA®, First-in-Class IL-15 Receptor Agonist for...
Morningstar· 5 days agoImmunityBio Announces FDA Approval of ANKTIVA®, First-in-Class IL-15 Receptor Agonist for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Designated an FDA Breakthrough Therapy, the novel immunotherapy ANKTIVA activates the body’s natural killer
ImmunityBio stock jumps as FDA clears bladder cancer therapy (NASDAQ:IBRX)
Seeking Alpha· 4 days agoShares of ImmunityBio (IBRX) surged 33% premarket after FDA clearance of its combination therapy for...
AI Model Predicts Inpatient Hypoglycemic Events
Medscape· 2 days agoA machine learning model designed to predict inpatient hypoglycemic events using only capillary blood glucose (CBG) showed excellent performance,...
